(Q36663803)

15 August 2017

1 reference

title

Drug treatment in precocious puberty (English)

1 reference

15 August 2017

Drug Treatment in Precocious Puberty (English)

1 reference

10.2165/00003495-199141050-00004

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199141050-00004

5 November 2022

author name string

M. D. Wheeler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712706

5 November 2022

D. M. Styne

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712706

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712706

5 November 2022

publication date

1 May 1991

1 reference

15 August 2017

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

717-728

1 reference

GnRH agonists and antagonists. Current clinical status

15 August 2017

cites work

1 reference

12 December 2020

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

1 reference

12 December 2020

Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions

1 reference

12 December 2020

Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole

1 reference

12 December 2020

Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty

1 reference

12 December 2020

Treatment of familial male precocious puberty with spironolactone and testolactone

1 reference

12 December 2020

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

12 December 2020

Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications

1 reference

12 December 2020

Variations in pattern of pubertal changes in girls

1 reference

12 December 2020

Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy

1 reference

12 December 2020

Effects of leuprolide in the treatment of central precocious puberty

1 reference

12 December 2020

Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules

1 reference

12 December 2020

Gonadotropin-Independent Familial Sexual Precocity with Premature Leydig and Germinal Cell Maturation (Familial Testotoxicosis): Effects of a Potent Luteinizing Hormone-Releasing Factor Agonist and Medroxyprogesterone Acetate Therapy in Four Cases*

1 reference

12 December 2020

Variations in the Pattern of Pubertal Changes in Boys

1 reference

12 December 2020

Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.

1 reference

12 December 2020

Effect of cyproterone acetate on adrenocortical function in children with precocious puberty

1 reference

12 December 2020

Recent advances in the diagnosis and management of sexual precocity

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetic characteristics of the gonadotropin-releasing hormone analog D-Ser(TBU)-6EA-10luteinizing hormone-releasing hormone (buserelin) after subcutaneous and intranasal administration in children with central precocious puberty

1 reference

12 December 2020

Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile

1 reference

12 December 2020

Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience

1 reference

12 December 2020

Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone

1 reference

12 December 2020

Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.

1 reference

12 December 2020

Cyproteroneacetate and ACTH Adrenal Function*

1 reference

12 December 2020

Depot leuprolide acetate for treatment of precocious puberty

1 reference

12 December 2020

The endocrine effects of ketoconazole

1 reference

12 December 2020

Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis

1 reference

12 December 2020

Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.

1 reference

12 December 2020

Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report

1 reference

12 December 2020

Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone

1 reference

12 December 2020

10.2165/00003495-199141050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1048916427

0 references

1 reference